Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome.

[1]  S. Priori,et al.  Gender differences in patients with Brugada syndrome and arrhythmic events: Data from a survey on arrhythmic events in 678 patients. , 2018, Heart rhythm.

[2]  S. Priori,et al.  Fever-related arrhythmic events in the multicenter Survey on Arrhythmic Events in Brugada Syndrome. , 2018, Heart rhythm.

[3]  P. Rattanawong,et al.  SCN5A mutation status increases the risk of major arrhythmic events in Asian populations with Brugada syndrome: systematic review and meta‐analysis , 2018, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[4]  L. Delahanty,et al.  Barriers and strategies for oral medication adherence among children and adolescents with Type 2 diabetes. , 2018, Diabetes research and clinical practice.

[5]  P. Brugada,et al.  Concomitant Brugada syndrome substrate ablation and epicardial abdominal cardioverter-defibrillator implantation in a child , 2018, HeartRhythm case reports.

[6]  P. Brugada,et al.  Implantable Cardioverter-De fi brillators in Children and Adolescents With Brugada Syndrome , 2022 .

[7]  S. Priori,et al.  Profile of patients with Brugada syndrome presenting with their first documented arrhythmic event: Data from the Survey on Arrhythmic Events in BRUgada Syndrome (SABRUS). , 2018, Heart rhythm.

[8]  S. Priori,et al.  Age of First Arrhythmic Event in Brugada Syndrome: Data From the SABRUS (Survey on Arrhythmic Events in Brugada Syndrome) in 678 Patients , 2017, Circulation. Arrhythmia and electrophysiology.

[9]  P. Brugada,et al.  A Clinical Score Model to Predict Lethal Events in Young Patients (≤19 Years) With the Brugada Syndrome. , 2017, The American journal of cardiology.

[10]  F. Sacher,et al.  The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk. , 2017, Heart rhythm.

[11]  Toshihiro Tanaka,et al.  Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome: A Japanese Multicenter Registry , 2017, Circulation.

[12]  P. Brugada,et al.  Brugada syndrome in the young: an assessment of risk factors predicting future events , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[13]  E. Behr,et al.  Impact of clinical and genetic findings on the management of young patients with Brugada syndrome. , 2016, Heart rhythm.

[14]  J. Brugada,et al.  Shock Reduction With Long-Term Quinidine in Patients With Brugada Syndrome and Malignant Ventricular Arrhythmia Episodes. , 2016, Journal of the American College of Cardiology.

[15]  A. Capucci,et al.  A New Electrocardiographic Marker of Sudden Death in Brugada Syndrome: The S-Wave in Lead I. , 2016, Journal of the American College of Cardiology.

[16]  S. Viskin,et al.  Management of Brugada Syndrome: Thirty-Three–Year Experience Using Electrophysiologically Guided Therapy With Class 1A Antiarrhythmic Drugs , 2015, Circulation. Arrhythmia and electrophysiology.

[17]  P. Brugada,et al.  Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience. , 2015, Journal of the American College of Cardiology.

[18]  P. Brugada,et al.  Drug-induced brugada syndrome in children: clinical features, device-based management, and long-term follow-up. , 2014, Journal of the American College of Cardiology.

[19]  P. Brugada,et al.  Life-threatening ventricular arrhythmias during ajmaline challenge in patients with Brugada syndrome: incidence, clinical features, and prognosis. , 2013, Heart rhythm.

[20]  M. Cárdenas,et al.  Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: a case series and literature review. , 2012, Heart rhythm.

[21]  A. Wilde,et al.  The diagnostic and therapeutic aspects of loss-of-function cardiac sodium channelopathies in children. , 2012, Heart rhythm.

[22]  S. Priori,et al.  [Risk stratification in Brugada syndrome]. , 2011, Giornale italiano di cardiologia.

[23]  H. Morita,et al.  SCN5A mutation is associated with early and frequent recurrence of ventricular fibrillation in patients with Brugada syndrome. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[24]  M Borggrefe,et al.  Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome: Results From the FINGER Brugada Syndrome Registry , 2010, Circulation.

[25]  J. Brugada,et al.  When Our Best Is Not Enough: The Death of a Teenager with Brugada Syndrome , 2009, Journal of cardiovascular electrophysiology.

[26]  Tohru Ohe,et al.  Fragmented QRS as a Marker of Conduction Abnormality and a Predictor of Prognosis of Brugada Syndrome , 2008, Circulation.

[27]  A. Wilde,et al.  Clinical Aspects and Prognosis of Brugada Syndrome in Children , 2007, Circulation.

[28]  M. Field,et al.  Outcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome: A Multicenter Study–Part 2 , 2006, Circulation.

[29]  J. Brugada,et al.  Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. , 1992, Journal of the American College of Cardiology.